NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Rohan Bareja
Cornell University - Ithaca / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1293108
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Rohan Bareja's MOST POPULAR ARTICLES
1-)
Suppression of insulin feedback enhances the efficacy of PI3K inhibitorsBD Hopkins, C Pauli, X Du, DG Wang, X Li, D Wu, SC Amadiume, ...Nature 560 (7719), 499-503, 20184012018
2-)
Patient derived organoids to model rare prostate cancer phenotypesL Puca, R Bareja, D Prandi, R Shaw, M Benelli, WR Karthaus, J Hess, ...Nature communications 9 (1), 1-10, 20182772018
3-)
Clinical features of neuroendocrine prostate cancerV Conteduca, C Oromendia, KW Eng, R Bareja, M Sigouros, A Molina, ...European journal of cancer 121, 7-18, 20192192019
4-)
A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer: efficacy and biomarkersClinical Cancer Research, clincanres. 1912.2018, 2018235*2018
5-)
Metastasis and immune evasion from extracellular cGAMP hydrolysisJ Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ...Cancer discovery 11 (5), 1212-1227, 20212072021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept